
Major Scope
- Cardiovascular Case Reports
- Oncology Case Reports
- Surgical Case Reports
- Gastroenterological Case Reports
- Neurological Case Reports
- Dermatological Case Reports
- Respiratory Case Reports
- Obstetrics/Gynecology Case Reports
- Nephrology Case Reports
- Immunology Case Reports
- Paediatric Case Reports
- Orthopedics Case Reports
- Dental Case Reports
Abstract
Citation: Ann Clin Case Rep. 2022;7(1):2199.DOI: 10.25107/2474-1655.2199
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report
Jo KJ, Kim T, Lim JK, Kim YA and Park SE*
Department of Pediatrics, Pusan National University Children’s Hospital, Republic of Korea
PDF Full Text Case Report | Open Access
Abstract:
Although Coronavirus Disease 2019 (COVID-19) vaccines have been associated with a low incidence of Multisystem Inflammatory Syndrome in Children (MIS-C), several MIS-C cases following COVID-19 vaccination have been reported globally. Here, we report a case of persistent fever, mucocutaneous inflammation, and elevated inflammatory markers after COVID-19 vaccination. A previously healthy 13-year-old boy presented with fever and headache for two days. He had received a second dose of COVID-19 vaccine (Pfizer-BioNTech BNT162b2) approximately nine weeks prior. Laboratory tests revealed elevated levels of inflammatory markers and Echocardiography revealed normal ventricular function and a normal coronary artery. He had no history of diagnosis of COVID-19, and the severe acute respiratory syndrome coronavirus-2 reverse transcriptase polymerase chain reaction result was negative. After admission, the patient developed a skin rash, bilateral conjunctival injection, abdominal pain, and hypotension. Based on diagnostic criteria, MIS-C was strongly suspected. We initiated intravenous gamma globulin and methylprednisolone. Following treatment, the symptoms improved, and inflammatory markers decreased. We report the first Korean child who developed MIS-C following COVID-19 vaccination.
Keywords:
Coronavirus Disease 2019 (COVID-19); COVID-19 vaccination; Multisystem inflammatory syndrome; Children
Cite the Article:
Jo KJ, Kim T, Lim JK, Kim YA, Park SE. Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report. Ann Clin Case Rep. 2022; 7: 2199..
Journal Basic Info
- Impact Factor: 5.253*
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
- PubMed NLM ID: 101702800